![Barry J. Wolfenson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barry J. Wolfenson
Corporate Officer/Principal bei
MEDIWOUND LTD.
Profil
Barry J.
Wolfenson is the founder of Vtail Healthcare Communications, serving as Chief Executive Officer since 2020.
Current jobs include Director at Sano Diagnostics LLC since 2019 and Executive VP-Strategy & Corporate Development at MediWound Ltd. since 2023.
Former jobs include Chief Executive Officer at WoundForce, Inc. from 2018 to 2021, Marketing Manager-Convatec Division at Bristol Myers Squibb Co. from 2011 to 2024, and Group President-Advanced Wound Care at Derma Sciences, Inc. from 2013 to 2017.
Education includes an undergraduate degree from Franklin & Marshall College conferred in 1989 and an MBA from Stephen M.
Ross School of Business conferred in 2001.
Aktive Positionen von Barry J. Wolfenson
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDIWOUND LTD. | Corporate Officer/Principal | 06.03.2023 |
Sano Diagnostics LLC
 Sano Diagnostics LLC Packaged SoftwareTechnology Services Develops care diagnostic platform | Direktor/Vorstandsmitglied | 01.05.2019 |
Vtail Healthcare Communications
 Vtail Healthcare Communications Packaged SoftwareTechnology Services Develops software platform for healthcare ecosystems | Vorstandsvorsitzender | 01.03.2020 |
Ehemalige bekannte Positionen von Barry J. Wolfenson
| Unternehmen | Position | Ende |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 27.10.2011 |
WoundForce, Inc.
 WoundForce, Inc. Miscellaneous Commercial ServicesCommercial Services Develops a novel drug for wound debridement | Vorstandsvorsitzender | 01.12.2021 |
| DERMA SCIENCES INC | Public Communications Contact | 27.10.2011 |
Ausbildung von Barry J. Wolfenson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
80
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Derma Sciences, Inc.
 Derma Sciences, Inc. Medical SpecialtiesHealth Technology Manufactures and markets skin & wound care products | Health Technology |
Franklin & Marshall College
 Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MediWound Ltd.
 MediWound Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes bio-therapeutic solutions for tissue repair and regeneration | Health Technology |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WoundForce, Inc.
WoundForce, Inc. Miscellaneous Commercial ServicesCommercial Services Develops a novel drug for wound debridement | Commercial Services |
Sano Diagnostics LLC
Sano Diagnostics LLC Packaged SoftwareTechnology Services Develops care diagnostic platform | Technology Services |
Vtail Healthcare Communications
Vtail Healthcare Communications Packaged SoftwareTechnology Services Develops software platform for healthcare ecosystems | Technology Services |
